8-[3-(4-acetylpiperazin-1-yl)prop-1-ynyl]-5-(3-aminopropyl)-3-methyl-2H-pyrazolo[4,3-c]quinolin-4-one;5-(3-aminopropyl)-8-(3-imidazol-1-ylprop-1-ynyl)-3-methyl-2H-pyrazolo[4,3-c]quinolin-4-one;5-(3-aminopropyl)-3-methyl-8-[3-(4-methylpiperazin-1-yl)prop-1-ynyl]-2H-pyrazolo[4,3-c]quinolin-4-one;5-(3-aminopropyl)-3-methyl-8-(3-morpholin-4-ylprop-1-ynyl)-2H-pyrazolo[4,3-c]quinolin-4-one;5-(3-aminopropyl)-3-methyl-8-(3-piperidin-1-ylprop-1-ynyl)-2H-pyrazolo[4,3-c]quinolin-4-one;5-(3-aminopropyl)-3-methyl-8-(3-pyrrolidin-1-ylprop-1-ynyl)-2H-pyrazolo[4,3-c]quinolin-4-one
C129H153N33O8 — CID 158845242
Data last refreshed: (MolForge compound catalog, from PubChem)
About 8-[3-(4-acetylpiperazin-1-yl)prop-1-ynyl]-5-(3-aminopropyl)-3-methyl-2H-pyrazolo[4,3-c]quinolin-4-one;5-(3-aminopropyl)-8-(3-imidazol-1-ylprop-1-ynyl)-3-methyl-2H-pyrazolo[4,3-c]quinolin-4-one;5-(3-aminopropyl)-3-methyl-8-[3-(4-methylpiperazin-1-yl)prop-1-ynyl]-2H-pyrazolo[4,3-c]quinolin-4-one;5-(3-aminopropyl)-3-methyl-8-(3-morpholin-4-ylprop-1-ynyl)-2H-pyrazolo[4,3-c]quinolin-4-one;5-(3-aminopropyl)-3-methyl-8-(3-piperidin-1-ylprop-1-ynyl)-2H-pyrazolo[4,3-c]quinolin-4-one;5-(3-aminopropyl)-3-methyl-8-(3-pyrrolidin-1-ylprop-1-ynyl)-2H-pyrazolo[4,3-c]quinolin-4-one
8-[3-(4-acetylpiperazin-1-yl)prop-1-ynyl]-5-(3-aminopropyl)-3-methyl-2H-pyrazolo[4,3-c]quinolin-4-one;5-(3-aminopropyl)-8-(3-imidazol-1-ylprop-1-ynyl)-3-methyl-2H-pyrazolo[4,3-c]quinolin-4-one;5-(3-aminopropyl)-3-methyl-8-[3-(4-methylpiperazin-1-yl)prop-1-ynyl]-2H-pyrazolo[4,3-c]quinolin-4-one;5-(3-aminopropyl)-3-methyl-8-(3-morpholin-4-ylprop-1-ynyl)-2H-pyrazolo[4,3-c]quinolin-4-one;5-(3-aminopropyl)-3-methyl-8-(3-piperidin-1-ylprop-1-ynyl)-2H-pyrazolo[4,3-c]quinolin-4-one;5-(3-aminopropyl)-3-methyl-8-(3-pyrrolidin-1-ylprop-1-ynyl)-2H-pyrazolo[4,3-c]quinolin-4-one (PubChem CID 158845242) has the molecular formula C129H153N33O8 and a molecular weight of 2293.87 g/mol. Its IUPAC name is 8-[3-(4-acetylpiperazin-1-yl)prop-1-ynyl]-5-(3-aminopropyl)-3-methyl-2H-pyrazolo[4,3-c]quinolin-4-one;5-(3-aminopropyl)-8-(3-imidazol-1-ylprop-1-ynyl)-3-methyl-2H-pyrazolo[4,3-c]quinolin-4-one;5-(3-aminopropyl)-3-methyl-8-[3-(4-methylpiperazin-1-yl)prop-1-ynyl]-2H-pyrazolo[4,3-c]quinolin-4-one;5-(3-aminopropyl)-3-methyl-8-(3-morpholin-4-ylprop-1-ynyl)-2H-pyrazolo[4,3-c]quinolin-4-one;5-(3-aminopropyl)-3-methyl-8-(3-piperidin-1-ylprop-1-ynyl)-2H-pyrazolo[4,3-c]quinolin-4-one;5-(3-aminopropyl)-3-methyl-8-(3-pyrrolidin-1-ylprop-1-ynyl)-2H-pyrazolo[4,3-c]quinolin-4-one.
Molecular Properties
| Compound Name | 8-[3-(4-acetylpiperazin-1-yl)prop-1-ynyl]-5-(3-aminopropyl)-3-methyl-2H-pyrazolo[4,3-c]quinolin-4-one;5-(3-aminopropyl)-8-(3-imidazol-1-ylprop-1-ynyl)-3-methyl-2H-pyrazolo[4,3-c]quinolin-4-one;5-(3-aminopropyl)-3-methyl-8-[3-(4-methylpiperazin-1-yl)prop-1-ynyl]-2H-pyrazolo[4,3-c]quinolin-4-one;5-(3-aminopropyl)-3-methyl-8-(3-morpholin-4-ylprop-1-ynyl)-2H-pyrazolo[4,3-c]quinolin-4-one;5-(3-aminopropyl)-3-methyl-8-(3-piperidin-1-ylprop-1-ynyl)-2H-pyrazolo[4,3-c]quinolin-4-one;5-(3-aminopropyl)-3-methyl-8-(3-pyrrolidin-1-ylprop-1-ynyl)-2H-pyrazolo[4,3-c]quinolin-4-one |
|---|---|
| PubChem CID | 158845242 |
| Molecular Formula | C129H153N33O8 |
| Molecular Weight | 2293.87 g/mol |
| Exact Mass | 2292.26 |
| IUPAC Name | 8-[3-(4-acetylpiperazin-1-yl)prop-1-ynyl]-5-(3-aminopropyl)-3-methyl-2H-pyrazolo[4,3-c]quinolin-4-one;5-(3-aminopropyl)-8-(3-imidazol-1-ylprop-1-ynyl)-3-methyl-2H-pyrazolo[4,3-c]quinolin-4-one;5-(3-aminopropyl)-3-methyl-8-[3-(4-methylpiperazin-1-yl)prop-1-ynyl]-2H-pyrazolo[4,3-c]quinolin-4-one;5-(3-aminopropyl)-3-methyl-8-(3-morpholin-4-ylprop-1-ynyl)-2H-pyrazolo[4,3-c]quinolin-4-one;5-(3-aminopropyl)-3-methyl-8-(3-piperidin-1-ylprop-1-ynyl)-2H-pyrazolo[4,3-c]quinolin-4-one;5-(3-aminopropyl)-3-methyl-8-(3-pyrrolidin-1-ylprop-1-ynyl)-2H-pyrazolo[4,3-c]quinolin-4-one |
| SMILES | CC(=O)N1CCN(CC#Cc2ccc3c(c2)c2n[nH]c(C)c2c(=O)n3CCCN)CC1.Cc1[nH]nc2c1c(=O)n(CCCN)c1ccc(C#CCN3CCCC3)cc21.Cc1[nH]nc2c1c(=O)n(CCCN)c1ccc(C#CCN3CCCCC3)cc21.Cc1[nH]nc2c1c(=O)n(CCCN)c1ccc(C#CCN3CCN(C)CC3)cc21.Cc1[nH]nc2c1c(=O)n(CCCN)c1ccc(C#CCN3CCOCC3)cc21.Cc1[nH]nc2c1c(=O)n(CCCN)c1ccc(C#CCn3ccnc3)cc21 |
| InChI | InChI=1S/C23H28N6O2.C22H28N6O.C22H27N5O.C21H25N5O2.C21H25N5O.C20H20N6O/c1-16-21-22(26-25-16)19-15-18(6-7-20(19)29(23(21)31)10-4-8-24)5-3-9-27-11-13-28(14-12-27)17(2)30;1-16-20-21(25-24-16)18-15-17(5-3-9-27-13-11-26(2)12-14-27)6-7-19(18)28(22(20)29)10-4-8-23;1-16-20-21(25-24-16)18-15-17(7-5-13-26-11-3-2-4-12-26)8-9-19(18)27(22(20)28)14-6-10-23;1-15-19-20(24-23-15)17-14-16(4-2-8-25-10-12-28-13-11-25)5-6-18(17)26(21(19)27)9-3-7-22;1-15-19-20(24-23-15)17-14-16(6-4-12-25-10-2-3-11-25)7-8-18(17)26(21(19)27)13-5-9-22;1-14-18-19(24-23-14)16-12-15(4-2-9-25-11-8-22-13-25)5-6-17(16)26(20(18)27)10-3-7-21/h6-7,15H,4,8-14,24H2,1-2H3,(H,25,26);6-7,15H,4,8-14,23H2,1-2H3,(H,24,25);8-9,15H,2-4,6,10-14,23H2,1H3,(H,24,25);5-6,14H,3,7-13,22H2,1H3,(H,23,24);7-8,14H,2-3,5,9-13,22H2,1H3,(H,23,24);5-6,8,11-13H,3,7,9-10,21H2,1H3,(H,23,24) |
| InChIKey | IYSYSOOWNQDVSI-UHFFFAOYSA-N |
| XLogP | 9.54 |
| TPSA | 527.00 Ų |
| H-Bond Donors | 12 |
| H-Bond Acceptors | 34 |
| Rotatable Bonds | 24 |
| Heavy Atoms | 170 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2293.87 |
| LogP ≤ 5 | 9.54 |
| H-Bond Donors ≤ 5 | 12 |
| H-Bond Acceptors ≤ 10 | 34 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'triple_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158845242 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.